Table 5 Utilisation of glucose lowering medications among T2DM patients

8.02 ± 0.65

10.08 ± 1.12

2.05 (−1.25 to 5.36)

0.2162

25.00

8.45 ± 0.49

8.441 ± 0.82

−0.01 (−1.83 to 1.82)

0.9924

−0.10

9.63 ± 0.59

11.88 ± 1.47

2.25 (−0.52 to 5.02)

0.1098

23.40

9.921 ± 0.66

8.36 ± 1.04

−1.57 (−4.06 to 0.93)

0.216

−15.80

7.34 ± 0.28

9.51 ± 1.10

2.17 (0.57 to 3.78)

0.0094

29.60

8.11 ± 0.32

9.67 ± 0.65

1.55 (0.28 to 2.83)

0.0175

19.20

8.68 ± 0.33

10.12 ± 1.04

1.45 (−0.23 to 3.14)

0.0903

16.70

8.46 ± 0.26

8.57 ± 0.47

0.11 (−0.91 to 1.12)

0.8308

1.30